Dig Dis Sci: 急性胰腺炎深静脉血栓形成与高死亡率相关

2022-07-31 xuyihan MedSci原创

急性胰腺炎是多种病因导致胰酶在胰腺内被激活后引起胰腺组织自身消化、水肿、出血甚至坏死的炎症反应。

急性胰腺炎 (AP) 是全球最常见因为胃肠道住院的原因之一。AP是一种早期出现细胞因子风暴的全身性疾病,后期会出现各种局部和感染性并发症。许多急性坏死性胰腺炎(ANP)患者需要延长住院时间甚至延长ICU治疗时间,这会增加发生血栓并发症的风险。由于预防性抗凝可导致各种延迟干预或增加出血和推迟的风险,而不使用抗凝药物则会增加四肢血栓的风险(eDVT),急性胰腺炎入院患者的 eDVT 风险尚未得到很好的探究。因此,研究人员进行了一项前瞻性研究,以确定AP发病率和与eDVT发展相关的可能风险因素。

研究人员前瞻性地招募了入院时存在急性胰腺炎的患者,并在入院期间每周进行一次 eDVT 筛查。血栓相关的评分如Well评分和 Padua评分也是每周计算一次。同时靠基于腹部增强 CT 扫描的 eDVT记录了静脉血栓形成的发生率,并使用多变量分析确定了危险因素。使用 Pearson 相关性计算 Well 评分、Padua 评分和 DVT 发展之间的相关性。

研究结果显示在入组的102名急性胰腺炎患者中,73.5%的患者患有坏死性胰腺炎。共有46名患者(45.1%)发生血栓形成:43名患者出现内脏静脉血栓形成;5名患者出现eDVT;1例出现肺栓塞。eDVT患者的BISAP评分较高(2.6 ± 0.9 vs 1.7 ± 0.8;p  = 0.039)、机械通气需求(60% vs 8.2%;p  = 0.008)和死亡率(60% vs 12.4%;p  = 0.022)也较高。Well评分≥2分对 eDVT 预测的敏感性和特异性分别为 80% 和 96.9%,与 Pauda 评分相比,它与eDVT 发展的相关性更好。

本项研究证实在需要入院治疗的急性胰腺炎患者中,DVT的发生率为5%。它与更高的疾病严重程度和死亡率有关。Well 评分可用于预测常规临床实践中eDVT 的发展。

原始出处:

Terence Susngi. et al. Deep Venous Thrombosis in Acute Pancreatitis Is Associated with High Mortality: A Prospective Study. Digestive Diseases and Sciences.2022.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013935, encodeId=73d32013935ef, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 06 07:58:39 CST 2023, time=2023-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698404, encodeId=80c0169840416, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sun Aug 14 19:58:39 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955603, encodeId=c02d1955603a0, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Oct 13 13:58:39 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483318, encodeId=b1b01483318ae, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Mon Aug 01 11:58:39 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013935, encodeId=73d32013935ef, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 06 07:58:39 CST 2023, time=2023-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698404, encodeId=80c0169840416, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sun Aug 14 19:58:39 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955603, encodeId=c02d1955603a0, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Oct 13 13:58:39 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483318, encodeId=b1b01483318ae, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Mon Aug 01 11:58:39 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
    2022-08-14 fusion
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013935, encodeId=73d32013935ef, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 06 07:58:39 CST 2023, time=2023-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698404, encodeId=80c0169840416, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sun Aug 14 19:58:39 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955603, encodeId=c02d1955603a0, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Oct 13 13:58:39 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483318, encodeId=b1b01483318ae, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Mon Aug 01 11:58:39 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
    2022-10-13 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013935, encodeId=73d32013935ef, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 06 07:58:39 CST 2023, time=2023-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698404, encodeId=80c0169840416, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sun Aug 14 19:58:39 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955603, encodeId=c02d1955603a0, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Oct 13 13:58:39 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483318, encodeId=b1b01483318ae, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Mon Aug 01 11:58:39 CST 2022, time=2022-08-01, status=1, ipAttribution=)]

相关资讯

Gut:华西医院最新研究发现,肥胖还喝酒,会让这种致死性急症发生风险更高!

GUT:肥胖是酒精引起重症急性胰腺炎的重要协同因素,大量摄入酒精诱导内脏脂肪分解释放游离脂肪酸是胰腺损伤和多器官功能障碍的关键。

CGH: 急性胰腺炎后他汀类药物使用与糖尿病发展的关系

胰腺炎可能会导致糖尿病,急性胰腺炎疾病发病的时候,很多患者都会出现血糖的升高,主要是应激导致血糖水平的升高,当患者胰腺炎如果治疗的比较及时,痊愈后,血糖水平也会逐渐降到正常。

急性胰腺炎合并腹内高压,如何处理

急性胰腺炎合并腹内高压教程,一定要看!

Dig Dis Sci: 乳酸林格氏液与正常盐水治疗急性胰腺炎效果差异比较

急性胰腺炎是多种病因导致胰酶在胰腺内被激活后引起胰腺组织自身消化、水肿、出血甚至坏死的炎症反应。

急性胰腺炎患者诊疗措施

通常脾动脉行走于胰体尾部上方,而脾静脉则位于体尾部后方,这对于分辨其前方的胰尾和后方的左侧肾上腺具有重要解剖学意义。胰尾各面均有腹膜遮盖,其余胰腺各部均为腹膜后器官。

Dig Dis Sci: 急性胰腺炎患者30天内再入院的危险因素和药物使用情况分析

急性胰腺炎是多种病因导致胰酶在胰腺内被激活后引起胰腺组织自身消化、水肿、出血甚至坏死的炎症反应。